Last Price
0.21
Today's Change
-0.015 (6.66%)
Day's Change
0.21 - 0.236
Trading Volume
230,424
Overview
Market Cap
4 Million
Shares Outstanding
2 Billion
Avg Volume
26,236,043
Avg Price (50 Days)
0.26
Avg Price (200 Days)
0.19
PE Ratio
0.00
EPS
0.00
Earnings Announcement
23-Jul-2026
Previous Close
0.23
Open
0.24
Day's Range
0.21 - 0.2355
Year Range
0.07 - 0.555
Trading Volume
230,424
Price Change Highlight
1 Day Change
-6.67%
5 Day Change
-22.22%
1 Month Change
-23.64%
3 Month Change
-30.00%
6 Month Change
170.97%
Ytd Change
-28.81%
1 Year Change
147.06%
3 Year Change
-27.08%
5 Year Change
-92.50%
10 Year Change
-90.67%
Max Change
-92.00%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc was founded in 2008 and is based in London, the United Kingdom.
Discussions
Be the first to like this.
Showing 0 of 0 comments
Post a Comment
Latest Videos
Apps
Top Articles
1
Stumbling and Mumbling
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
{uid}
{comment}
Just now